Source: MarketScreener

Misonix: MISONIX : REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS (Form 8-K)

(marketscreener.com) MISONIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS FARMINGDALE, N.Y., September 2, 2021 - Misonix, Inc. , a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudited financial results for the fiscal 2021 fourth...https://www.marketscreener.com/quote/stock/MISONIX-INC-10101/news/MISONIX-REPORTS-FOURTH-QUARTER-AND-FISCAL-YEAR-2021-FINANCIAL-RESULTS-Form-8-K-36313778/?utm_medium=RSS&utm_content=20210902

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
1-25
Stavros G. Vizirgianakis's photo - President & CEO of Misonix

President & CEO

Stavros G. Vizirgianakis

CEO Approval Rating

78/100

Read more